ARCHIVES

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

This article is from The Cancer Letter archive.

Vol. 21 No. 32 | August 11, 1995

Download PDF Visit The Full Archive

Related Articles

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

Breaking With Tradition, NIH Director Heads Obama’s Search for NCI Director.

February 12, 2010

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006